Follow the Data: It Is Time to Incentivize the Use of Drug-Eluting Stents and Balloons

J Vasc Interv Radiol. 2022 Oct;33(10):1159-1160. doi: 10.1016/j.jvir.2022.06.014.
No abstract available

Publication types

  • Comment

MeSH terms

  • Drug-Eluting Stents*
  • Everolimus
  • Humans
  • Paclitaxel
  • Percutaneous Coronary Intervention*
  • Stents
  • Treatment Outcome

Substances

  • Everolimus
  • Paclitaxel